Edaravone suspension for oral administration | Patent Number 10987341

US 10987341 B2
Application Number16872741
Publication NumberUS 20200268712 A1
Pendency11 months, 20 days
Filled DateMay 12, 2020
Priority DateNov 1, 2019
Publication DateAug 27, 2020
Expiration DateOct 31, 2039
Inventor/ApplicantsTadashi Miyazawa
Tetsuo Hayama
Kouji Hayashi
Tomohiro Takahashi
Munetomo Matsuda
Tomoyuki Omura
ExaminesCHANNAVAJJALA, LAKSHMI SARADA
Art Unit1611
Technology Center1600
Assignments
Mitsubishi Chemical Group Corporation
Current
Mitsubishi Chemical Group Corporation
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.